Sodium chloride

Nippon Shokubai’s Newly Developed Material Contributed the Successful Demonstration of Groundbreaking Renewable Seawater Desalination Plant in Hawaii

Retrieved on: 
Thursday, February 29, 2024

The RO system is a technology that involves the pressurization of seawater or wastewater over an RO membrane to remove salts (such as NaCl) and impurities.

Key Points: 
  • The RO system is a technology that involves the pressurization of seawater or wastewater over an RO membrane to remove salts (such as NaCl) and impurities.
  • Nippon Shokubai and Trevi Systems developed the draw solution to be separated from the recovered water using low grade thermal heat (Photo 1).
  • This developed draw solution was used in the demonstration pilot plant (500m3/day) operated by Trevi Systems on the islands of Hawaii (*2).
  • About NIPPON SHOKUBAI CO., LTD.: Nippon Shokubai utilizes the unique technology to manufacture chemicals such as ethylene oxide, acrylic acids, catalysts, superabsorbent polymers.

Compilation of quality review of documents (QRD) on stylistic matters in product information

Retrieved on: 
Sunday, March 10, 2024

29 February 2024

Key Points: 
    • 29 February 2024
      EMA/25090/2002 rev.23*
      Human Medicines Division

      Compilation of QRD decisions on stylistic matters in product information
      Issues
      Abbreviations

      Connected problems
      Subscript and superscript

      QRD Suggestions
      Acronyms must be written in their standard form; e.g.

    • Cmax, Cmax
      Abbreviations and

      Not always understood,

      Non-standard abbreviations and acronyms should be avoided, and the term should be written out in full.

    • The same applies when stating the pharmaceutical form in section 3 of the SmPC and section 4 of the labelling;
      i.e.
    • critical steps prior to administration of the product should also be included (section 5 of Annex IIIA).
    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 2/23

      Issues

      Connected problems

      QRD Suggestions

      emphasise in the labelling
      the special handling prior
      to administration of the
      product.

    • Consistency

      Inconsistencies in style are

      Once a particular style or house style has been selected, it must be used consistently throughout the text.

    • Tradename 150 mg solution for injection in pre-filled syringe
      Tradename 150 mg solution for injection in pre-filled pen

      information annexes?

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 3/23

      Issues
      Desiccant

      Connected problems

      QRD Suggestions

      For medicinal products

      The foil of blister packs containing a desiccant must be clearly labelled to show which blister pocket contains

      packaged with a desiccant

      the desiccant.

    • For bottles containing a desiccant, a similar statement should also be considered provided there

      mistake the desiccant for a

      is available space.

    • It can only be included in brackets in section 3 of the

      where can this be

      SmPC and section 4 of the labelling.

    • Direct speech should only
      be used in section 6 of the SmPC for instructions about shelf-life, storage, handling and disposal.
    • The term ?drug? though can be used in the product information annexes when it is part of a standard set of
      terms (e.g.
    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 5/23

      Issues
      Foreign terms

      Connected problems

      QRD Suggestions

      Foreign terms, particularly

      Foreign terms must be written in italics; e.g.

    • Patients can be referred to as ?he? or

      physician is often referred

      as ?she? when the medicinal product is exclusively for use by males or females.

    • if the product in question might be

      measurements are

      used by elderly patients), in brackets after the metric measures in the English text.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 6/23

      Issues

      Connected problems

      QRD Suggestions

      product name is composed
      of MAH+INN?

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 7/23

      Issues

      Connected problems

      QRD Suggestions
      MT: English
      BG: Bulgarian
      NL: Dutch
      CZ: Czech or English at applicant?s discretion.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 14/23

      Issues

      Connected problems

      QRD Suggestions
      considered, e.g.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 16/23

      Issues
      Symbols: Non-Unicode

      Connected problems

      QRD Suggestions

      The use of non-Unicode

      Only Unicode symbols must be used in submitted product information annexes.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 20/23

      Issues

      Connected problems

      Units: SI base units -

      International Standard

      litre

      base units have been
      introduced in the European
      Union with Council
      Directive 80/181/EEC of
      20.12.79 (O.J.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 23/23

B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL)

Retrieved on: 
Tuesday, February 13, 2024

BETHLEHEM, Pa., Feb. 13, 2024 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL), the fifth product in its portfolio of Heparin premixed bags.

Key Points: 
  • BETHLEHEM, Pa., Feb. 13, 2024 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL), the fifth product in its portfolio of Heparin premixed bags.
  • This new addition to the portfolio enhances the Company's ability to serve the diverse needs of healthcare facilities and their patients for this high-alert medication.
  • The B. Braun Heparin portfolio is manufactured using EXCEL® IV Containers which are not made with natural rubber latex, DEHP or PVC, placing a priority on patient and environmental safety.
  • Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.

This salt alternative could help reduce blood pressure. So why are so few people using it?

Retrieved on: 
Tuesday, January 30, 2024

Excess salt (sodium) increases the risk of high blood pressure so everyone with hypertension is advised to reduce salt in their diet.

Key Points: 
  • Excess salt (sodium) increases the risk of high blood pressure so everyone with hypertension is advised to reduce salt in their diet.
  • It can be used just like regular salt and most people don’t notice any important difference in taste.
  • Switching to potassium-enriched salt is feasible in a way that cutting salt intake is not.

What is potassium-enriched salt?

  • Potassium-enriched salts replace some of the sodium chloride that makes up regular salt with potassium chloride.
  • They’re also called low-sodium salt, potassium salt, heart salt, mineral salt, or sodium-reduced salt.

What is the evidence?


We have strong evidence from a randomised trial of 20,995 people that switching to potassium-enriched salt lowers blood pressure and reduces the risks of stroke, heart attacks and early death. The participants had a history of stroke or were 60 years of age or older and had high blood pressure.
An overview of 21 other studies suggests much of the world’s population could benefit from potassium-enriched salt. The World Health Organisation’s 2023 global report on hypertension highlighted potassium-enriched salt as an “affordable strategy” to reduce blood pressure and prevent cardiovascular events such as strokes.

What should clinical guidelines say?

  • We teamed up with researchers from the United States, Australia, Japan, South Africa and India to review 32 clinical guidelines for managing high blood pressure across the world.
  • While many guidelines recommend increasing dietary potassium intake, and all refer to reducing sodium intake, only two guidelines – the Chinese and European – recommend using potassium-enriched salt.

Why do so few people use it?

  • Few people know a simple switch to potassium-enriched salt can help lower blood pressure and reduce the risk of a stroke and heart disease.
  • Several Australian retailers stock potassium-enriched salt but there is usually only one brand available, and it is often on the bottom shelf or in a special food aisle.


A 2021 review found potassium-enriched salts were marketed in only 47 countries and those were mostly high-income countries. Prices ranged from the same as regular salt to almost 15 times greater. Even though generally more expensive, potassium-enriched salt has the potential to be highly cost effective for disease prevention.

Preventing harm

  • People with serious kidney disease are already advised to avoid regular salt and to avoid foods high in potassium.
  • No harm from potassium-enriched salt has been recorded in any trial done to date, but all studies were done in a clinical setting with specific guidance for people with kidney disease.
  • In some countries, potassium-enriched salt is recommended to the entire community because the potential benefits are so large.

What will happen next?

  • We are working with the taskforce to update Australian hypertension management guidelines, and to promote the new guidelines to health professionals.
  • The next switch to iodised and potassium-enriched salt offers at least the same potential for global health gains.
  • But we need to make it happen in a fraction of the time.
  • Alta Schutte receives funding from the National Health and Medical Research Council of Australia, the Medical Research Future Fund, and NSW Health.
  • She is Company Secretary of the Australian Cardiovascular Alliance, Board Member of Hypertension Australia, and Co-Chair of the National Hypertension Taskforce of Australia.

LYT PROUDLY ANNOUNCES STRATEGIC EXPANSION INTO INTERNATIONAL MARKETS BY UNVEILING GROUNDBREAKING NEXTGEN SNOWPLOW PREEMPTION TECHNOLOGY FOR U.S AND CANADIAN MARKETS

Retrieved on: 
Thursday, January 4, 2024

SANTA CLARA, Calif., Jan. 4, 2024 /PRNewswire/ -- LYT, a leader in NextGen intelligent connected traffic technology solutions, announced today its strategic international expansion into Canada and the Toronto region with the launch of LYT.snow, an advanced snowplow signal priority solution that enables snowplows to travel through intersections safely and efficiently to clear snow quickly so travelers can continue to safely move through their community.

Key Points: 
  • "Our technology is not just about managing traffic; it's about creating smarter, more responsive transportation networks that benefit both cities and their residents."
  • For Canadian markets, snow removal creates an annual traffic congestion problem for cities and residents.
  • "Our snowplow traffic signal prioritization technology represents a significant advancement in urban mobility and emergency response systems," added Menard.
  • To learn more about LYT.snow preemption technology, please visit the LYT.snow product page .

Holiday Pet Dangers

Retrieved on: 
Wednesday, November 15, 2023

MINNEAPOLIS, Nov. 15, 2023 /PRNewswire/ -- The holidays are best spent with family and friends, not taking a trip to the animal hospital. With the trifecta of Thanksgiving, Christmas and New Years Eve coming up, the toxicology experts at Pet Poison Helpline want to warn pet lovers about the many dangers that face pets during this festive season.

Key Points: 
  • With the trifecta of Thanksgiving, Christmas and New Years Eve coming up, the toxicology experts at Pet Poison Helpline want to warn pet lovers about the many dangers that face pets during this festive season.
  • Meinke also contacted Pet Poison Helpline, who then worked with the medical team at BluePearl to identify the lily, diagnose and treat his pets.
  • "Many holiday treats include chocolate, and are often left sitting out on counters and dinner tables," said Dr. Schmid.
  • This year, we want pet lovers to remember the holidays for all the joy and happiness, not an emergency room visit."

Compass Minerals Announces Suspension of Lithium Project Pending Regulatory Clarity in Utah

Retrieved on: 
Thursday, November 2, 2023

Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today announced that, until it has clarity on the evolving regulatory climate in Utah, it will be suspending indefinitely any further investment in its planned lithium project.

Key Points: 
  • Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today announced that, until it has clarity on the evolving regulatory climate in Utah, it will be suspending indefinitely any further investment in its planned lithium project.
  • It is anticipated that the lithium project would create in excess of an additional 100 jobs in the area.
  • As a result, Compass Minerals will be indefinitely suspending any further investment in its lithium project in Utah beyond certain already committed items associated with the early stages of construction of its commercial scale demonstration unit.
  • “First, our board will only authorize further investment in this project if the evolving regulatory climate in Utah encourages responsible lithium development like we have been pursuing.

What causes lithium-ion battery fires? Why are they so intense? And how should they be fought? An expert explains

Retrieved on: 
Thursday, September 28, 2023

But what if I told you this idyllic drive could turn into a nightmare, with the faint smell of something burning?

Key Points: 
  • But what if I told you this idyllic drive could turn into a nightmare, with the faint smell of something burning?
  • This month we have had at least two large lithium-ion battery fires in Australia – one in the Sydney airport car park and another one more recently at the Bouldercombe battery storage site in Queensland.

What causes these fires?

    • They’re the same powerhouses that fuel our smartphones
      and laptops – celebrated for their ability to store heaps of energy in a small
      space.
    • In fact, from 2010 to June 2023, only four electric vehicle battery fires had been recorded in Australia.
    • In extreme cases, it causes the battery to catch fire or explode.
    • The onset and intensification of lithium-ion battery fires can be traced to multiple causes, including user behaviour such as improper charging or physical damage.

What to do when a fire has started?

    • That’s because lithium-ion batteries have a rather unwelcome talent for chemical reactions when they come into contact with water.
    • Instead of snuffing out the flames, water can actually fuel the fire and cause it to intensify.
    • This is because the water’s reaction with lithium produces flammable hydrogen gas, adding more of a fire hazard to an already perilous situation.
    • This is why these battery fires are a particular concern in confined spaces such as a garage, where noxious gases can accumulate quickly.

What to do if your car catches fire

    • First, get to know your EV inside and out.
    • What about sensors that could alert you to a problem before it turns into a crisis?
    • Avoid using fast chargers as your
      go-to, because these can cause the battery to heat up more quickly.

Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection

Retrieved on: 
Wednesday, September 6, 2023

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL.

Key Points: 
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL.
  • Key Warning: Concomitant use of ceftriaxone and Calcium Gluconate in Sodium Chloride Injection is contraindicated in neonates (28 days of age or younger.)
  • “The approval of calcium gluconate injection, a key injectable in shortage, reflects our commitment to addressing immediate patient needs for essential medicines.
  • According to IQVIA®, U.S. annual sales for calcium gluconate in sodium chloride injection for the 12 months ended June 2023 were $107 million.

EQS-News: Vortex Energy Closes Purchase of Additional Mineral License in Newfoundland

Retrieved on: 
Tuesday, August 1, 2023

Vancouver, British Columbia — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) ("Vortex” or the "Company") is pleased to announce that it has closed the previously announced purchase (the “Transaction”) of an additional mineral license contiguous to the northern border of its Robinsons River Salt Property in Newfoundland and Labrador (the “Mineral License”) from Galloper Gold Corp. (“Galloper”).

Key Points: 
  • Vancouver, British Columbia — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) ("Vortex” or the "Company") is pleased to announce that it has closed the previously announced purchase (the “Transaction”) of an additional mineral license contiguous to the northern border of its Robinsons River Salt Property in Newfoundland and Labrador (the “Mineral License”) from Galloper Gold Corp. (“Galloper”).
  • The Company paid C$162,800 in cash and issued 750,000 common shares of the Company (“Vortex Shares”) to Galloper in connection with the closing of the Transaction.
  • Paul Sparkes, Chief Executive Officer of the Company, commented, “Combining the Robinsons River Salt Property with the Mineral License will create synergies of scale and we believe will improve the exploration potential of the Robinsons River Salt Property.
  • In addition, all Vortex Shares issued pursuant to the Transaction shall be subject to a statutory four month hold period pursuant to applicable Canadian securities laws.